Optiscan Imaging Ltd has released a press release.
Optiscan Entitlement Issue Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Trading Halt
- OIL March 2023 Quarterly Report and Appendix 4C
- Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
- Optiscan Intends to pursue De Novo Pathway for InVivage
- OIL Appendix 4D and 31 December 2022 Half-year report
Later from Optiscan Imaging
- Entitlement Offer Results and Shortfall Announcement
- OIL June 2023 Quarterly Report and Appendix 4C
- Optiscan Achieves Telepathology Milestone
- OIL Appendix 4E and June 2023 Annual Report
- Optiscan Correlates with Histology in Breast Study
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging